Elucidata
PrivateLast Round
Series A
Sep 27, 2022
Total Funding Raised
$17.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elucidata operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in September 2022.
Elucidata is a healthtech company that provides an AI and cloud-based data analytics platform, Polly, for life sciences research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elucidata Comparables
Compare Elucidata with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TetraScience | 85% | |
| Data4Cure, Inc. | 83% | |
| DNAnexus | 79% |
For institutional investors. Book with your work email.
Elucidata Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 27, 2022 | ||||
| VC Round | Feb 4, 2021 | ||||
| Seed | Jun 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elucidata Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eight Roads Ventures | Series A |
| IvyCap Ventures | Series A, VC Round |
| F-Prime Capital | Series A |
| Hyperplane Venture Capital | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 77% MoM.
- Jan 31, 2026
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
Elucidata Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elucidata's valuation, stock price, and market status.
Is Elucidata a public or private company?
Elucidata is a private company.
What is the current stock price of Elucidata?
Elucidata is a private company, so its shares have no public market price. Caplight tracks Elucidata's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elucidata worth (valuation)?
Valuation information for Elucidata is not publicly available.
Can I buy Elucidata stock?
Elucidata shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elucidata's last funding round?
Elucidata's most recent funding round was Series A on September 27, 2022.
Who are the main investors in Elucidata?
Key investors in Elucidata include Eight Roads Ventures, IvyCap Ventures, Hyperplane Venture Capital.
Will Elucidata IPO soon?
No public IPO plans have been announced for Elucidata.
How can I track Elucidata secondary market activity?
Caplight tracks bids, offers, and trades in Elucidata's shares on secondary markets.